h_line.gif (79 Byte)



Annexes III - VII of the In Vitro Diagnostic Directive 98/79/EC (IVDD)

 

ANNEX III - EC DECLARATION OF CONFORMITY:

A conformity assessment procedure in which the manufacturer himself declares the compliance of his devices with the IVDD. This is required for all in vitro diagnostic devices, except those listed in Annex II or devices for performance evaluation. For devices for self-testing the manufacturer has to lodge in addition an application for examination of the design, according to section 6, with a Notified body.

The examination of the design is a complete assessment of the technical file for compliance with the essential requirements according to Annex I.

 

ANNEX IV - FULL QUALITY ASSURANCE SYSTEM:

Most comprehensive conformity assessment procedure for the aspect of quality systems. A full quality assurance system has to include all steps from the product development right through to the end control. The manufacturer may choose the harmonized standards EN ISO 13485 as the basis of his quality system or use an equivalent quality system suitable to fulfill the requirements of the IVDD. This procedure is applicable for all products according to Annex II and may be implemented for devices for self-testing. Section 4 describes the examination of the design of the product, which applies to Annex II List A devices. This Section is similar to Annex V - EC Type-Examination with the difference, that in-house test results obtained by the manufacturer under his full quality management system can be acknowledged by the Notified body. For the devices according to Annex II List A verification of the manufactured products (batch release) by a Notified body, according to section 6, is necessary.

 

ANNEX V - EC TYPE-EXAMINATION:

A conformity assessment procedure for the product design which involves examination and testing of representative samples of the device by a Notified Body and certification that the device meets the applicable essential requirements. Manufacturer supplied test reports should originate from a third party and fulfill certain criteria. Testing by the manufacturer is possible under supervision of the Notified body. EC type-examination may be applicable to List A devices and devices for self-testing. In each case Annex V is only allowable in combination with either Annex VI or Annex VII.

 

ANNEX VI - EC VERIFICATION:

A conformity assessment procedure in which the Notified Body examines and tests every individual device or devices taken on a statistical basis, if the manufacturer manufactures homogeneous batches. The Notified Body releases individual devices or batches. EC Verification may be applied to Annex II List B devices and for devices for self-testing in combination with an EC type examination.

This conformity assessment process refers to a quality system has to include all steps (with the exception of the design phase) from the raw material supply right through to the end control. Application of the quality system must ensure that the devices conform to the type described in the EC type-examination certificate. The manufacturer may choose the harmonized standard standards EN ISO 13485 as the basis of his quality system. Annex VII, in combination with Annex V, may be followed for all Annex II IVDs and devices for self-testing. For Annex II List A products verification of the manufactured products (batch release) by a Notified body, according to section 5, is necessary.




mdc medical device certification GmbH, Kriegerstraße 6, 70191 Stuttgart, Germany
Telefon: +49-(0)711 253597-0; Fax: +49-(0)711 253597-10; e-mail: mdc@mdc-ce.de

Last updated: 2010-04-22

© mdc medical device certification GmbH / §Legal Disclaimer§